Antibiotic: Resistance of enterococci in Germany;Antibiotikaresistenz der enterokokken in Deutschland

Medizinische Klinik

Volumn 92, Issue 8, 1997, Pages 464-468

  Wallrauch, Claudia ^a   Elsner, Elmar ^a   Milatovic, Danica ^a   Cremer, Josef ^a   Braveny, Ilja ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ampicillinresistance; Enterococcus; Glycopeptide resistance; Highlevel aminoglycoside resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; PENICILLIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CROSS RESISTANCE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; GERMANY; NONHUMAN; PENICILLIN RESISTANCE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; STREPTOCOCCUS;

EID: 0030961051     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044913     Document Type: Article

References (17)

1. Arthur, M., P. Courvalin: Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37 (1993), 1563-1571.
2. Bonten, J. M., C. A. Gaillard, F H. van Thiel, S. van der Geest, E E. Stobberingh: Colonization and infection with Enterococcus faecalis in intensive care units: the role of antimicrobial agents. Antimicrob. Agents Chemother. 39 (1995), 2783-2786.
3. Centers for Disease Control and Prevention: Nosocomial enterococci resistant to vancomycin: United States, 1989-1993 National Nosocomial Infection Surveillance. MMWR 42 (1993), 597-599.
4. Centers for Disease Control and Prevention: Recommendations for preventing the spread of vancomycin resistance. MMWR 44 RR. 12 (1995), 1-13.
5. Clark, N. C., R. C. Cooksey, B. C. Hill, J. M. Swenson, F. C. Tenover: Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Anamicrob Agents Chemother. 37 (1993), 2311-2317.
6. Collins, L. A., G. J. Malanaski, G. M. Eliopoulos, C. B. Wennersten, M. J. Ferraro, R. C. Moellering Jr.: In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin resistant gram-positive organisms Antimicrob. Agents Chemother. 37 (1993), 598-601.
7. DIN-Taschenbuch 222: Medizinische Mikrobiologie und Immunologie; Norm 58940 Teil 4, Beuth, Berlin 1992
8. Douboyas, J., A. Tsakris: Prevalence of antibiotic resistance among enterococci isolated in Greece. J. antimicrob. Chemother. 35 (1995), 236-238.
9. Facklam, R. R., M. D Collins: Identification of enterococcus species isolated from human infections by a conventional test scheme J. clin. Microbiol. 27 (1989), 731-734.
10. Frieden, T. R. Emergence of vancomycin-resistant enterococci in New York City. Lancet 342 (1993), 76-79.
11. Gordts, B., H. van Landuyt, M. Ieven, P. Vandarne, H. Goossens: Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J. clin. Microbiol. 33 (1995), 2842-2846.
12. Healy, S. P., M. J. Zervos. Mechanisms of resistance of enterococci to antimicrobial agents. Rev. med. Microbiol 6 (1995), 70-76.
13. Hospital Infection Control Practices Advisory Committee (HICPAC) Recommendations for preventing the spread of vancomycin resistance. Infect Control. Hosp. Epidem 16 (1995), 105-113
14. Jones, R. N., H. S. Sader, M. E. Erwin, S. C. Anderson and the Enterococcus Study Group: Emerging multiply resistant enterococci among clinical isolates. Diagn. microbiol. infect. Dis. 21 (1995), 85-93.
15. Leclerq, R , E. Derlot, J Duval, P Courvalin: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. New Engl. J. Med. 319 (1988), 157-161.
16. Linden, P. K , A. W. Pasculle, R. Manez, D J. Kramer, J. J. Fung, A. D. Pinna, S Kusne. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin. infect. Dis. 22 (1996), 663-670.
17. Maki, D. G., W. A. Agger: Enterococcal bacteremia. Clinical features, the risk of endocarditis, and management Medicine (Baltimore) 67 (1988), 248-269.